Naturhouse HealthXMAD:NTH -0.78%81 EBITDA Margin % is 26.08% as of Dec. 2025, which is 17% below its 10-year median of 31.42. GuruFocus rates XMAD:NTH with a GF Score™ of 81/100 and a GF Value™ of €1.62 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,953 Consumer Packaged Goods companies, Naturhouse Health ranks better than 94.06% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Naturhouse Health's EBITDA for the
six
months ended in Dec. 2025 was €5.55 Mil. Naturhouse Health's Revenue for the
six
months ended in Dec. 2025 was €21.27 Mil. Therefore, Naturhouse Health's EBITDA margin for the quarter that ended in Dec. 2025 was 26.08%.
Naturhouse Health (XMAD:NTH) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Naturhouse Health EBITDA Margin % Related Terms
Naturhouse Health EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Naturhouse Health's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAD:NTH vs KHC, GIS, JBS: EBITDA Margin % Comparison
For the Packaged Foods subindustry, Naturhouse Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Naturhouse Health EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Naturhouse Health's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Naturhouse Health's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Naturhouse Health (XMAD:NTH) has a EBITDA Margin % of 26.08% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Naturhouse Health and its competitors. This is 17% below median its historical median of 31.42. Over the past decade, Naturhouse Health's EBITDA Margin % has ranged from 27.38 to 36.29. According to the industry distribution chart, Naturhouse Health ranks #116 out of 1953 companies in the Consumer Packaged Goods industry, placing it in the top 5.9%.
Is Naturhouse Health's EBITDA Margin % too high?
Naturhouse Health's current EBITDA Margin % of 26.08% is 17% below median its 10-year median of 31.42. Over the past 10 years, this metric has ranged from a low of 27.38 to a high of 36.29. The Consumer Packaged Goods industry median EBITDA Margin % is 9.00. Naturhouse Health's value of 26.08% is 189.8% above this industry median. Based on the distribution chart, Naturhouse Health ranks #116 out of 1953 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Naturhouse Health has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Naturhouse Health's EBITDA Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Naturhouse Health ranks #116 out of 1953 companies for EBITDA Margin %. This places Naturhouse Health in the top 6% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.00. Naturhouse Health's value of 26.08% is 189.8% above this benchmark. Historically, Naturhouse Health's own EBITDA Margin % has ranged from 27.38 to 36.29 over the past decade. While the company's 10-year median is 31.42 vs. the industry median of 9.00, Naturhouse Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 9.00, based on 1,953 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Naturhouse Health's current EBITDA Margin % of 26.08% is 189.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Naturhouse Health and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 9.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naturhouse Health's current EBITDA Margin % is 26.08%, which is 17% below median its own 10-year median of 31.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturhouse Health stock overvalued right now?
Based on GuruFocus' analysis, Naturhouse Health (XMAD:NTH) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.62, compared to a current price of €2.53 — trading 56.2% above its estimated fair value. The current EBITDA Margin % is 26.08%, which is 17% below median its 10-year median of 31.42 and 189.8% above the Consumer Packaged Goods industry median of 9.00. Naturhouse Health's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Naturhouse Health (XMAD:NTH), the current EBITDA Margin % is 26.08% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Naturhouse Health (XMAD:NTH) Overvalued in 2026?
Based on GuruFocus' analysis, Naturhouse Health stock appears to be overvalued.
The current stock price of €2.53 is trading 56.2% above its estimated GF Value™ of €1.62.
GuruFocus considers Naturhouse Health to be Significantly Overvalued.
Key valuation signals for XMAD:NTH:
EBITDA Margin %: 26.08% (17% below median its 10-year median of 31.42)
GF Value™: €1.62 vs. price of €2.53 (56.2% above fair value)
Industry Position: 189.8% above the Consumer Packaged Goods median (#116 of 1953)
No single metric tells the full story. See the XMAD:NTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Naturhouse Health SA provides nutrition & weight management products. The activity of the company is the export, wholesale, and retail sales of all kinds of products related to dietetics, herbal remedies, and natural cosmetics, as well as the preparation, promotion, creation, edition, dissemination, sale, and distribution of all kinds of magazines, books, and brochures and the marketing of dietary products, herbal remedies, and natural cosmetics. This activity is mainly carried out through franchisees and its stores. The geographical segments of the company are Spain, France, Italy, Poland, and Other countries.
81GF Score
Get the complete analysis for XMAD:NTH
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:NTH has been successfully added to your 
